DC-U4106
DC-U4106 is a small molecule inhibitor targeting USP8 (Kd: 4.7 μM) that induces the degradation of estrogen receptor alpha (ERα) via the ubiquitin-proteasome pathway. It demonstrates potent anti-proliferative activity in breast cancer cell models with low cytotoxicity, supporting its use for in vitro and in vivo research into ER-positive cancers.
Product Specifications
CAS Number
2410534-62-0
Field of Research
Cell Biology, Molecular Biology, Protein Biochemistry
Smiles
Cc1n[nH]c (C) c1Oc1c (O) cc (O) c2c1oc (cc2=O) -c1ccc (cc1) N1CCN (CC1) c1ccccn1
Molecular Formula
C29H27N5O5
Molecular Weight
525.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
126868-FITC 100 µL
LONRF1 (LON Peptidase N-terminal Domain and RING Finger Protein 1, RING Finger Protein 191, RNF191, FLJ23749) (FITC)
Sign In for Pricing
View Details 
MBS1484315-01 0.02 mg (E-Coli)
Recombinant Human Diphosphoinositol polyphosphate phosphohydrolase 3-alpha (NUDT10)
Sign In for Pricing
View Details MBS1484315-02 0.1 mg (E-Coli)
Recombinant Human Diphosphoinositol polyphosphate phosphohydrolase 3-alpha (NUDT10)
Sign In for Pricing
View Details MBS1484315-03 0.02 mg (Yeast)
Recombinant Human Diphosphoinositol polyphosphate phosphohydrolase 3-alpha (NUDT10)
Sign In for Pricing
View Details MBS1484315-04 0.1 mg (Yeast)
Recombinant Human Diphosphoinositol polyphosphate phosphohydrolase 3-alpha (NUDT10)
Sign In for Pricing
View Details